Skip to main content
Top
Published in: BMC Infectious Diseases 1/2013

Open Access 01-12-2013 | Research article

Patient characteristics but not virulence factors discriminate between asymptomatic and symptomatic E. coli bacteriuria in the hospital

Authors: Jonas Marschall, Marilyn L Piccirillo, Betsy Foxman, Lixin Zhang, David K Warren, Jeffrey P Henderson, For the CDC Prevention Epicenters Program

Published in: BMC Infectious Diseases | Issue 1/2013

Login to get access

Abstract

Background

Escherichia coli is a common cause of asymptomatic and symptomatic bacteriuria in hospitalized patients. Asymptomatic bacteriuria (ASB) is frequently treated with antibiotics without a clear indication. Our goal was to determine patient and pathogen factors suggestive of ASB.

Methods

We conducted a 12-month prospective cohort study of adult inpatients with E. coli bacteriuria seen at a tertiary care hospital in St. Louis, Missouri, USA. Urine cultures were taken at the discretion of treating physicians. Bacterial isolates were tested for 14 putative virulence genes using high-throughput dot-blot hybridization.

Results

The median age of the 287 study patients was 65 (19–101) years; 78% were female. Seventy percent had community-acquired bacteriuria. One-hundred ten (38.3%) patients had ASB and 177 (61.7%) had symptomatic urinary tract infection (sUTI). Asymptomatic patients were more likely than symptomatic patients to have congestive heart failure (p = 0.03), a history of myocardial infarction (p = 0.01), chronic pulmonary disease (p = 0.045), peripheral vascular disease (p = 0.04), and dementia (p = 0.03). Patients with sUTI were more likely to be neutropenic at the time of bacteriuria (p = 0.046). Chronic pulmonary disease [OR 2.1 (95% CI 1.04, 4.1)] and dementia [OR 2.4 (95% CI 1.02, 5.8)] were independent predictors for asymptomatic bacteriuria. Absence of pyuria was not predictive of ASB. None of the individual virulence genes tested were associated with ASB nor was the total number of genes.

Conclusions

Asymptomatic E. coli bacteriuria in hospitalized patients was frequent and more common in patients with dementia and chronic pulmonary disease. Bacterial virulence factors could not discriminate symptomatic from asymptomatic bacteriurias. Asymptomatic E. coli bacteriuria cannot be predicted by virulence screening.
Literature
1.
go back to reference Lin K, Fajardo K: Screening for asymptomatic bacteriuria in adults: evidence for the U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med. 2008, 149 (1): 20-24. 10.7326/0003-4819-149-1-200807010-00006.CrossRef Lin K, Fajardo K: Screening for asymptomatic bacteriuria in adults: evidence for the U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med. 2008, 149 (1): 20-24. 10.7326/0003-4819-149-1-200807010-00006.CrossRef
2.
go back to reference Nicolle LE: Asymptomatic bacteriuria: review and discussion of the IDSA guidelines. Int J Antimicrob Agents. 2006, 28 (Suppl 1): S42-S48.CrossRefPubMed Nicolle LE: Asymptomatic bacteriuria: review and discussion of the IDSA guidelines. Int J Antimicrob Agents. 2006, 28 (Suppl 1): S42-S48.CrossRefPubMed
3.
go back to reference Nicolle LE, Bradley S, Colgan R, Rice JC, Schaeffer A, Hooton TM: Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis. 2005, 40 (5): 643-654. 10.1086/427507.CrossRefPubMed Nicolle LE, Bradley S, Colgan R, Rice JC, Schaeffer A, Hooton TM: Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis. 2005, 40 (5): 643-654. 10.1086/427507.CrossRefPubMed
4.
go back to reference Dalal S, Nicolle L, Marrs CF, Zhang L, Harding G, Foxman B: Long-term Escherichia coli asymptomatic bacteriuria among women with diabetes mellitus. Clin Infect Dis. 2009, 49 (4): 491-497. 10.1086/600883.CrossRefPubMedPubMedCentral Dalal S, Nicolle L, Marrs CF, Zhang L, Harding G, Foxman B: Long-term Escherichia coli asymptomatic bacteriuria among women with diabetes mellitus. Clin Infect Dis. 2009, 49 (4): 491-497. 10.1086/600883.CrossRefPubMedPubMedCentral
5.
go back to reference Gupta K, Scholes D, Stamm WE: Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA. 1999, 281 (8): 736-738. 10.1001/jama.281.8.736.CrossRefPubMed Gupta K, Scholes D, Stamm WE: Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA. 1999, 281 (8): 736-738. 10.1001/jama.281.8.736.CrossRefPubMed
6.
go back to reference Cai T, Mazzoli S, Mondaini N, Meacci F, Nesi G, D’Elia C, Malossini G, Boddi V, Bartoletti R: The role of asymptomatic bacteriuria in young women with recurrent urinary tract infections: to treat or not to treat?. Clin Infect Dis. 2012, 55 (6): 771-777. 10.1093/cid/cis534.CrossRefPubMed Cai T, Mazzoli S, Mondaini N, Meacci F, Nesi G, D’Elia C, Malossini G, Boddi V, Bartoletti R: The role of asymptomatic bacteriuria in young women with recurrent urinary tract infections: to treat or not to treat?. Clin Infect Dis. 2012, 55 (6): 771-777. 10.1093/cid/cis534.CrossRefPubMed
7.
go back to reference Gross PA, Patel B: Reducing antibiotic overuse: a call for a national performance measure for not treating asymptomatic bacteriuria. Clin Infect Dis. 2007, 45 (10): 1335-1337. 10.1086/522183.CrossRefPubMed Gross PA, Patel B: Reducing antibiotic overuse: a call for a national performance measure for not treating asymptomatic bacteriuria. Clin Infect Dis. 2007, 45 (10): 1335-1337. 10.1086/522183.CrossRefPubMed
8.
go back to reference Mabbett AN, Ulett GC, Watts RE, Tree JJ, Totsika M, Ong CL, Wood JM, Monaghan W, Looke DF, Nimmo GR: Virulence properties of asymptomatic bacteriuria Escherichia coli. Int J Med Microbiol. 2009, 299 (1): 53-63. 10.1016/j.ijmm.2008.06.003.CrossRefPubMed Mabbett AN, Ulett GC, Watts RE, Tree JJ, Totsika M, Ong CL, Wood JM, Monaghan W, Looke DF, Nimmo GR: Virulence properties of asymptomatic bacteriuria Escherichia coli. Int J Med Microbiol. 2009, 299 (1): 53-63. 10.1016/j.ijmm.2008.06.003.CrossRefPubMed
9.
go back to reference Takahashi A, Kanamaru S, Kurazono H, Kunishima Y, Tsukamoto T, Ogawa O, Yamamoto S: Escherichia coli isolates associated with uncomplicated and complicated cystitis and asymptomatic bacteriuria possess similar phylogenies, virulence genes, and O-serogroup profiles. J Clin Microbiol. 2006, 44 (12): 4589-4592. 10.1128/JCM.02070-06.CrossRefPubMedPubMedCentral Takahashi A, Kanamaru S, Kurazono H, Kunishima Y, Tsukamoto T, Ogawa O, Yamamoto S: Escherichia coli isolates associated with uncomplicated and complicated cystitis and asymptomatic bacteriuria possess similar phylogenies, virulence genes, and O-serogroup profiles. J Clin Microbiol. 2006, 44 (12): 4589-4592. 10.1128/JCM.02070-06.CrossRefPubMedPubMedCentral
10.
go back to reference Hull RA, Rudy DC, Wieser IE, Donovan WH: Virulence factors of Escherichia coli isolates from patients with symptomatic and asymptomatic bacteriuria and neuropathic bladders due to spinal cord and brain injuries. J Clin Microbiol. 1998, 36 (1): 115-117.PubMedPubMedCentral Hull RA, Rudy DC, Wieser IE, Donovan WH: Virulence factors of Escherichia coli isolates from patients with symptomatic and asymptomatic bacteriuria and neuropathic bladders due to spinal cord and brain injuries. J Clin Microbiol. 1998, 36 (1): 115-117.PubMedPubMedCentral
11.
go back to reference Graham JC, Leathart JB, Keegan SJ, Pearson J, Bint A, Gally DL: Analysis of Escherichia coli strains causing bacteriuria during pregnancy: selection for strains that do not express type 1 fimbriae. Infect Immun. 2001, 69 (2): 794-799. 10.1128/IAI.69.2.794-799.2001.CrossRefPubMedPubMedCentral Graham JC, Leathart JB, Keegan SJ, Pearson J, Bint A, Gally DL: Analysis of Escherichia coli strains causing bacteriuria during pregnancy: selection for strains that do not express type 1 fimbriae. Infect Immun. 2001, 69 (2): 794-799. 10.1128/IAI.69.2.794-799.2001.CrossRefPubMedPubMedCentral
12.
go back to reference Hooton TM, Scholes D, Stapleton AE, Roberts PL, Winter C, Gupta K, Samadpour M, Stamm WE: A prospective study of asymptomatic bacteriuria in sexually active young women. N Engl J Med. 2000, 343 (14): 992-997. 10.1056/NEJM200010053431402.CrossRefPubMed Hooton TM, Scholes D, Stapleton AE, Roberts PL, Winter C, Gupta K, Samadpour M, Stamm WE: A prospective study of asymptomatic bacteriuria in sexually active young women. N Engl J Med. 2000, 343 (14): 992-997. 10.1056/NEJM200010053431402.CrossRefPubMed
13.
go back to reference Benson M, Jodal U, Agace W, Hellstrom M, Marild S, Rosberg S, Sjostrom M, Wettergren B, Jonsson S, Svanborg C: Interleukin (IL)-6 and IL-8 in children with febrile urinary tract infection and asymptomatic bacteriuria. J Infect Dis. 1996, 174 (5): 1080-1084. 10.1093/infdis/174.5.1080.CrossRefPubMed Benson M, Jodal U, Agace W, Hellstrom M, Marild S, Rosberg S, Sjostrom M, Wettergren B, Jonsson S, Svanborg C: Interleukin (IL)-6 and IL-8 in children with febrile urinary tract infection and asymptomatic bacteriuria. J Infect Dis. 1996, 174 (5): 1080-1084. 10.1093/infdis/174.5.1080.CrossRefPubMed
14.
go back to reference Rodhe N, Lofgren S, Strindhall J, Matussek A, Molstad S: Cytokines in urine in elderly subjects with acute cystitis and asymptomatic bacteriuria. Scand J Prim Health Care. 2009, 27 (2): 74-79. 10.1080/02813430902757634.CrossRefPubMedPubMedCentral Rodhe N, Lofgren S, Strindhall J, Matussek A, Molstad S: Cytokines in urine in elderly subjects with acute cystitis and asymptomatic bacteriuria. Scand J Prim Health Care. 2009, 27 (2): 74-79. 10.1080/02813430902757634.CrossRefPubMedPubMedCentral
15.
go back to reference Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ, The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 1992, 101 (6): 1644-1655. 10.1378/chest.101.6.1644.CrossRefPubMed Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ, The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 1992, 101 (6): 1644-1655. 10.1378/chest.101.6.1644.CrossRefPubMed
16.
go back to reference Bauer RJ, Zhang L, Foxman B, Siitonen A, Jantunen ME, Saxen H, Marrs CF: Molecular epidemiology of 3 putative virulence genes for Escherichia coli urinary tract infection-usp, iha, and iroN(E. coli). J Infect Dis. 2002, 185 (10)): 1521-1524.CrossRefPubMed Bauer RJ, Zhang L, Foxman B, Siitonen A, Jantunen ME, Saxen H, Marrs CF: Molecular epidemiology of 3 putative virulence genes for Escherichia coli urinary tract infection-usp, iha, and iroN(E. coli). J Infect Dis. 2002, 185 (10)): 1521-1524.CrossRefPubMed
17.
go back to reference Zhang L, Srinivasan U, Marrs CF, Ghosh D, Gilsdorf JR, Foxman B: Library on a slide for bacterial comparative genomics. BMC Microbiol. 2004, 4: 12-10.1186/1471-2180-4-12.CrossRefPubMedPubMedCentral Zhang L, Srinivasan U, Marrs CF, Ghosh D, Gilsdorf JR, Foxman B: Library on a slide for bacterial comparative genomics. BMC Microbiol. 2004, 4: 12-10.1186/1471-2180-4-12.CrossRefPubMedPubMedCentral
18.
go back to reference Silver SA, Baillie L, Simor AE: Positive urine cultures: A major cause of inappropriate antimicrobial use in hospitals?. Can J Infect Dis Med Microbiol. 2009, 20 (4): 107-111.PubMedPubMedCentral Silver SA, Baillie L, Simor AE: Positive urine cultures: A major cause of inappropriate antimicrobial use in hospitals?. Can J Infect Dis Med Microbiol. 2009, 20 (4): 107-111.PubMedPubMedCentral
19.
go back to reference Gandhi T, Flanders SA, Markovitz E, Saint S, Kaul DR: Importance of urinary tract infection to antibiotic use among hospitalized patients. Infect Control Hosp Epidemiol. 2009, 30 (2): 193-195. 10.1086/593951.CrossRefPubMed Gandhi T, Flanders SA, Markovitz E, Saint S, Kaul DR: Importance of urinary tract infection to antibiotic use among hospitalized patients. Infect Control Hosp Epidemiol. 2009, 30 (2): 193-195. 10.1086/593951.CrossRefPubMed
20.
go back to reference Colgan R, Nicolle LE, McGlone A, Hooton TM: Asymptomatic bacteriuria in adults. Am Fam Physician. 2006, 74 (6): 985-990.PubMed Colgan R, Nicolle LE, McGlone A, Hooton TM: Asymptomatic bacteriuria in adults. Am Fam Physician. 2006, 74 (6): 985-990.PubMed
21.
go back to reference Ariathianto Y: Asymptomatic bacteriuria - prevalence in the elderly population. Aust Fam Physician. 2011, 40 (10): 805-809.PubMed Ariathianto Y: Asymptomatic bacteriuria - prevalence in the elderly population. Aust Fam Physician. 2011, 40 (10): 805-809.PubMed
22.
go back to reference Lavigne JP, Boutet-Dubois A, Laouini D, Combescure C, Bouziges N, Mares P, Sotto A: Virulence potential of Escherichia coli strains causing asymptomatic bacteriuria during pregnancy. J Clin Microbiol. 2011, 49 (11): 3950-3953. 10.1128/JCM.00892-11.CrossRefPubMedPubMedCentral Lavigne JP, Boutet-Dubois A, Laouini D, Combescure C, Bouziges N, Mares P, Sotto A: Virulence potential of Escherichia coli strains causing asymptomatic bacteriuria during pregnancy. J Clin Microbiol. 2011, 49 (11): 3950-3953. 10.1128/JCM.00892-11.CrossRefPubMedPubMedCentral
23.
go back to reference Hancock V, Ferrieres L, Klemm P: Biofilm formation by asymptomatic and virulent urinary tract infectious Escherichia coli strains. FEMS Microbiol Lett. 2007, 267 (1): 30-37. 10.1111/j.1574-6968.2006.00507.x.CrossRefPubMed Hancock V, Ferrieres L, Klemm P: Biofilm formation by asymptomatic and virulent urinary tract infectious Escherichia coli strains. FEMS Microbiol Lett. 2007, 267 (1): 30-37. 10.1111/j.1574-6968.2006.00507.x.CrossRefPubMed
24.
go back to reference Roos V, Ulett GC, Schembri MA, Klemm P: The asymptomatic bacteriuria Escherichia coli strain 83972 outcompetes uropathogenic E. coli strains in human urine. Infect Immun. 2006, 74 (1): 615-624. 10.1128/IAI.74.1.615-624.2006.CrossRefPubMedPubMedCentral Roos V, Ulett GC, Schembri MA, Klemm P: The asymptomatic bacteriuria Escherichia coli strain 83972 outcompetes uropathogenic E. coli strains in human urine. Infect Immun. 2006, 74 (1): 615-624. 10.1128/IAI.74.1.615-624.2006.CrossRefPubMedPubMedCentral
25.
go back to reference Zdziarski J, Svanborg C, Wullt B, Hacker J, Dobrindt U: Molecular basis of commensalism in the urinary tract: low virulence or virulence attenuation?. Infect Immun. 2008, 76 (2): 695-703. 10.1128/IAI.01215-07.CrossRefPubMed Zdziarski J, Svanborg C, Wullt B, Hacker J, Dobrindt U: Molecular basis of commensalism in the urinary tract: low virulence or virulence attenuation?. Infect Immun. 2008, 76 (2): 695-703. 10.1128/IAI.01215-07.CrossRefPubMed
26.
go back to reference Henderson JP, Crowley JR, Pinkner JS, Walker JN, Tsukayama P, Stamm WE, Hooton TM, Hultgren SJ: Quantitative metabolomics reveals an epigenetic blueprint for iron acquisition in uropathogenic Escherichia coli. PLoS Pathog. 2009, 5 (2): e1000305-10.1371/journal.ppat.1000305.CrossRefPubMedPubMedCentral Henderson JP, Crowley JR, Pinkner JS, Walker JN, Tsukayama P, Stamm WE, Hooton TM, Hultgren SJ: Quantitative metabolomics reveals an epigenetic blueprint for iron acquisition in uropathogenic Escherichia coli. PLoS Pathog. 2009, 5 (2): e1000305-10.1371/journal.ppat.1000305.CrossRefPubMedPubMedCentral
27.
go back to reference Vigil PD, Stapleton AE, Johnson JR, Hooton TM, Hodges AP, He Y, Mobley HL: Presence of Putative Repeat-in-Toxin Gene tosA in Escherichia coli Predicts Successful Colonization of the Urinary Tract. MBio. 2011, 2: 3-CrossRef Vigil PD, Stapleton AE, Johnson JR, Hooton TM, Hodges AP, He Y, Mobley HL: Presence of Putative Repeat-in-Toxin Gene tosA in Escherichia coli Predicts Successful Colonization of the Urinary Tract. MBio. 2011, 2: 3-CrossRef
28.
go back to reference Svanborg C, Bergsten G, Fischer H, Godaly G, Gustafsson M, Karpman D, Lundstedt AC, Ragnarsdottir B, Svensson M, Wullt B: Uropathogenic Escherichia coli as a model of host-parasite interaction. Curr Opin Microbiol. 2006, 9 (1): 33-39. 10.1016/j.mib.2005.12.012.CrossRefPubMed Svanborg C, Bergsten G, Fischer H, Godaly G, Gustafsson M, Karpman D, Lundstedt AC, Ragnarsdottir B, Svensson M, Wullt B: Uropathogenic Escherichia coli as a model of host-parasite interaction. Curr Opin Microbiol. 2006, 9 (1): 33-39. 10.1016/j.mib.2005.12.012.CrossRefPubMed
29.
go back to reference Hernandez JG, Sunden F, Connolly J, Svanborg C, Wullt B: Genetic control of the variable innate immune response to asymptomatic bacteriuria. PLoS One. 2011, 6 (11): e28289-10.1371/journal.pone.0028289.CrossRefPubMedPubMedCentral Hernandez JG, Sunden F, Connolly J, Svanborg C, Wullt B: Genetic control of the variable innate immune response to asymptomatic bacteriuria. PLoS One. 2011, 6 (11): e28289-10.1371/journal.pone.0028289.CrossRefPubMedPubMedCentral
30.
go back to reference Hawn TR, Scholes D, Wang H, Li SS, Stapleton AE, Janer M, Aderem A, Stamm WE, Zhao LP, Hooton TM: Genetic variation of the human urinary tract innate immune response and asymptomatic bacteriuria in women. PLoS One. 2009, 4 (12): e8300-10.1371/journal.pone.0008300.CrossRefPubMedPubMedCentral Hawn TR, Scholes D, Wang H, Li SS, Stapleton AE, Janer M, Aderem A, Stamm WE, Zhao LP, Hooton TM: Genetic variation of the human urinary tract innate immune response and asymptomatic bacteriuria in women. PLoS One. 2009, 4 (12): e8300-10.1371/journal.pone.0008300.CrossRefPubMedPubMedCentral
Metadata
Title
Patient characteristics but not virulence factors discriminate between asymptomatic and symptomatic E. coli bacteriuria in the hospital
Authors
Jonas Marschall
Marilyn L Piccirillo
Betsy Foxman
Lixin Zhang
David K Warren
Jeffrey P Henderson
For the CDC Prevention Epicenters Program
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2013
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-13-213

Other articles of this Issue 1/2013

BMC Infectious Diseases 1/2013 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.